Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | CNR1 | P21554 | 17/20 | 0.44 |
| ▸ | CNR2 | P34972 | 11/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5202867 | 0.92 | CNR1 (0.45) | TRPA1CNR1CNR2HDAC4 | |
| SCHEMBL5203142 | 0.90 | ALDH1A1 (0.48) | TRPA1CNR1CNR2HDAC4 | |
| SCHEMBL5202699 | 0.89 | CNR1 (0.44) | CNR1CNR2 | |
| SCHEMBL5206175 | 0.87 | HDAC4 (0.48) | CNR1CNR2HDAC4 | |
| SCHEMBL5202925 | 0.83 | CNR1 (0.48) | CNR1CNR2 | |
| SCHEMBL4822168 | 0.83 | CNR1 (0.61) | CNR1CNR2 | |
| SCHEMBL5201393 | 0.80 | TRPA1 (0.53) | TRPA1CNR1 | |
| SCHEMBL5206207 | 0.80 | CNR1 (0.51) | CNR1CNR2 | |
| SCHEMBL5203380 | 0.78 | HDAC4 (0.42) | TRPA1CNR1CNR2HDAC4 | |
| SCHEMBL4822971 | 0.78 | CNR1 (0.66) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490043-A4 | SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS | MERCK & CO INC (US) | 2007-05-30 | — | — | EP | disclosed |
| EP-1490043-A2 | SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS | Merck & Co., Inc. (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003082190-A2 | SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2003-10-09 | — | — | WO | disclosed |